卵巢癌治疗的最新动向
摘要
手术治疗仍是卵巢癌最主要的治疗方式。年轻的Ⅰ期卵巢癌者经保守性手术可保留生育功能,术后不增加复发机会。中、晚期者初次或二次手术能达到理想减瘤术是提高预后的关键。二次减瘤术若这不到理想减瘤术则难以延长生存期。紫杉醇加卡铂联合化疗是目前晚期卵巢癌的首选方案。维持化疗可能延长复发时间,但难以延长总生存期,其确切效果尚难肯定。
出处
《国外医学（妇产科学分册）》
2003年第4期213-216,共4页
Foreign Medical Sciences(Obstet Gynecol Fascicle)
参考文献22
-
1Zanetta G, Chiari S, Rota S, et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecal, 1997,104(9):1030-1035.
-
2Balbi C,C, Compagna R, Musone R, et al. Cytoreductive surgery in patients with stage IV ovarian carcinoma. Minerva Ginecol,2001,53[Suppl 1]:105-109.
-
3Scarabelli C, Gallo A, Franceschi LD, et al. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma. Cancer, 2000,88(2):389-397.
-
4Bristow RE, Lagasse LD, Karlan BY. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Cancer, 1996,78(10):2049-2062.
-
5Rose PG, Nerenstone S, Brady M, et al. A phase Ⅲ randomized study of interval secondary cytoreduction in patients with advanced stage ovarian carcinoma with suboptimal residual disease:a Gynecologic Oncology Group Study. Program and abstracts of the 38th Annual Meeting of The ASCO; May 18-21,2002,Orlando, Florida. Abstract 802.
-
6Vaccarello L, Rubin SD, Viamis V, et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol, 1995,57(1):61.
-
7Partridge EE, Barnes MN. Epithelial ovarian cancer: Prevention, diagnosis, and treatment. CA Cancer J Clin, 1999,49{5):297-320.
-
8Mutch DG. Surgical management of ovarian cancer. Semin Oncol,2002,29[Suppl 1]:3-8.
-
9Nicoletto MD, Tumolo S, Talamini R, et 81. Surgical second look in ovarian cancer, a randomized study in patients with laparoscopic complete remission-a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group study. J Clin Oncol, 1997,15(3):994-999.
-
10McGuire WP, Hoskin WJ, Brady MF, et 81. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage Ⅲ and stage IV ovarian cancer. New Engl J Med, 1996,334(1):1-6.
-
1肝肿瘤[J].国外科技资料目录（医药卫生）,2000(10):128-131.
-
2臧荣余,程玺.卵巢癌二次减瘤术的合理性及病例选择[J].肿瘤学杂志,2005,11(4):243-244.
-
3戴志远,臧荣余.晚期卵巢黏液性囊腺癌的二次减瘤术[J].北京医学,2005,27(12):755-755.
-
4于丽,中健,栗宝华,蔡桂凤.卵巢癌手术治疗新进展[J].国外医学（妇产科学分册）,2002,29(5):296-299. 被引量：2
-
5浦红,何成章,丁宝瑛,吕蓓.新辅助化疗在晚期卵巢癌中的应用[J].中国临床医学,2001,8(4):417-418. 被引量：7
-
6高永良.卵巢癌治疗的进展[J].国外医学（妇产科学分册）,1999,26(2):88-93. 被引量：6
-
7谷文飞,樊杨,宁辛珠.复发性卵巢癌两种治疗方法的预后分析[J].宁夏医学杂志,2013,35(2):178-179. 被引量：5
-
8胡柯,狄文.晚期卵巢癌理想减瘤术预测研究进展[J].国外医学（妇产科学分册）,2007,34(6):430-432. 被引量：1
-
9黄俊莲,侯振山,安武,虎瑞娟,陈丽,杜雪冻,付丽华,赵清霞.卡铂联合化疗治疗恶性肿瘤58例近期疗效观察[J].河南肿瘤学杂志,1992,5(4):54-55. 被引量：1
-
10杜淑芹,徐延民,臧红平.卵巢癌患者联合化疗的护理[J].齐鲁护理杂志,2005,11(6):626-627. 被引量：1
